Monopar Therapeutics Inc.
MNPR
$77.19
$1.251.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.07% | -4.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.55% | 0.39% | |||
| Operating Income | -26.55% | -0.39% | |||
| Income Before Tax | -40.11% | 6.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.11% | 6.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.11% | 6.53% | |||
| EBIT | -26.55% | -0.39% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -37.62% | 6.68% | |||
| Normalized Basic EPS | -37.65% | 6.69% | |||
| EPS Diluted | -37.62% | 6.68% | |||
| Normalized Diluted EPS | -37.65% | 6.69% | |||
| Average Basic Shares Outstanding | 1.80% | 0.15% | |||
| Average Diluted Shares Outstanding | 1.80% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||